| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.926 | 3.115 | 48.970 | 115.053 | 289.069 | 358.304 | 512.149 | 642.097 | 713.644 | 933.252 |
| Total Income - EUR | 7.926 | 3.369 | 48.982 | 115.068 | 289.208 | 358.549 | 512.167 | 642.198 | 714.031 | 1.020.874 |
| Total Expenses - EUR | 17.173 | 18.125 | 20.021 | 60.476 | 119.474 | 233.468 | 329.674 | 500.616 | 754.638 | 895.506 |
| Gross Profit/Loss - EUR | -9.247 | -14.756 | 28.960 | 54.591 | 169.735 | 125.081 | 182.493 | 141.582 | -40.606 | 125.368 |
| Net Profit/Loss - EUR | -9.485 | -14.857 | 26.721 | 53.443 | 166.843 | 121.747 | 177.986 | 135.288 | -43.396 | 102.157 |
| Employees | 1 | 1 | 1 | 2 | 3 | 5 | 3 | 4 | 4 | 6 |
Check the financial reports for the company - Kaliophion Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.398 | 11.806 | 66.891 | 288.048 | 270.033 | 889.704 | 798.921 | 783.295 | 460.492 | 207.927 |
| Current Assets | 4.378 | 569 | 13.707 | 28.261 | 163.002 | 188.684 | 243.449 | 106.088 | 131.357 | 86.021 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
| Receivables | 323 | 484 | 9.490 | 27.016 | 24.375 | 23.240 | 7.466 | 6.849 | 74.725 | 143 |
| Cash | 4.055 | 85 | 4.217 | 1.244 | 138.627 | 165.444 | 235.982 | 99.239 | 56.628 | 85.878 |
| Shareholders Funds | -5.655 | -20.467 | 6.601 | 59.922 | 212.960 | 295.525 | 399.072 | 230.460 | 79.913 | 28.083 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.431 | 32.842 | 73.997 | 256.387 | 220.075 | 782.896 | 643.352 | 658.996 | 511.996 | 265.955 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kaliophion Medical Srl